Patient Support

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, PAN Foundation offers her thoughts on the session and feedback from the audience at PAP 2024 in Philadelphia.

Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes.

In an interview with Pharma Commerce Associate Editor Don Tracy, Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, Rx4Good provides insight on engaging multiple healthcare groups.

In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.

With out-of-pocket healthcare costs resulting in financial issues for patients, a cross-sectional study closely examines whether they are linked to more premature deaths.

Navigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag.

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics.

A Carrum Health/PWC report surveys benefit managers spanning various self-insured employers in an effort to determine ways to improve the cancer treatment experience, especially from a cost perspective.

An investigation evaluates whether SNAP benefits can also influence hypertension patients’ lack of medication adherence.

The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.

Cabenuva (cabotegravir + rilpivirine) showed superior efficacy in maintaining viral load suppression in patients with HIV compared with standard of care daily oral antiretroviral treatment.

Properly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.

Cohort study explores value-based insurance designs, while also determining how one’s place of residency can potentially play a role.

Researchers explore the proportion of approved drugs in the Canadian marketplace that utilize manufacturer-sponsored patient support programs, along with the types of medications that are more likely to do so.

And the need to boost awareness of this critical healthcare resource.

Health Affairs study investigates the consequences of patient medication abandonment surrounding oral HIV pre-exposure prophylaxis.

Including patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.

A non-randomized control trial investigates whether older adults with multiple chronic conditions can benefit by receiving more specialized services.

As providers and healthcare professionals recognize the potential of long-acting injectables to fight the opioid epidemic, many are actively transitioning from oral options to injectables.

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.

The group—known as the Innovators' Network—is meant to serve as a link between entrepreneurs, providers, researchers, and payers while they strive to combat cardiovascular disease.